Companies: 10,795·Total market cap: $144.5T

E-therapeutics Plc

E-therapeutics Plc

ETXPFOTCHealthcare

$0.13

+$0.00(+0.00%)

Market Cap$75963547

P/E Ratio—

52W High$0.13

52W Low$0.13

Avg Volume993

Open$0.13

Beta0.42

E-therapeutics Plc (ETXPF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ETXPF · net income · updated Jun 15, 2026

Core profitability metrics

ETXPF · net income · margin · TTM · CAGR

Net income was −$14.9M for FY2025 (fiscal year ending 2025-01-31), down 33.2% year-over-year. Net profit margin was —.

FY2025 Net Income−$14.9M▼ -33.2% YoY

Trailing 12M (TTM)−$26.1Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change-33.2%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 15, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · ETXPF net income history · ETXPF profit margin

Annual net income data

ETXPF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$14.9M▼ 33.2%—$0

FY2024Loss−$11.2M▼ 35.0%-3511.3%$318,000

FY2023Loss−$8.3M▲ +23.7%-1741.9%$475,000

FY2022Loss−$10.8M▼ 114.4%-1691.2%$641,421

FY2021Loss−$5.1M▼ 63.5%-1162.2%$435,304

Net income vs peers (Healthcare)

ETXPF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

E-therapeutics PlcYOU

ETXPF

−$14.9M-33.2%—

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

E-therapeutics Plc (ETXPF) reported net income of −$14.9M for FY2025 (fiscal year ending 2025-01-31), down 33.2% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

E-therapeutics Plc has not yet achieved annual profitability based on available data (15 fiscal years). The company has reported net losses across all available periods.

E-therapeutics Plc's net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "E-therapeutics Plc net worth" — the company's market capitalization is a separate figure from ETXPF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ETXPF net income · 4 questions

E-therapeutics Plc is not currently profitable on an annual basis. The company reported a net loss of $14.9M for FY2025.

is ETXPF profitabledoes ETXPF make a profitETXPF profitabilityETXPF profitable company

▸ Source: FMP /income-statement · GAAP · E-therapeutics Plc · E-therapeutics Plc SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026